• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持免疫治疗期间自我效能和自我管理的患者及护理人员教育——一项综合综述

Patient and Caregiver Education to Support Self-Efficacy and Self-Management During Immunotherapy-An Integrative Review.

作者信息

Rothausen Camilla S, Dieperink Karin B, Ruhlmann Christina H, Pappot Helle, Tolstrup Lærke K

机构信息

Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

Department of Oncology, Odense University Hospital, Odense, Denmark.

出版信息

Psychooncology. 2025 Mar;34(3):e70100. doi: 10.1002/pon.70100.

DOI:10.1002/pon.70100
PMID:40011212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11865008/
Abstract

BACKGROUND

Immune checkpoint inhibitors (ICI) have improved cancer treatment, but this treatment can lead to immune-related adverse events (irAEs). Effective patient and caregiver education is essential to better management of irAEs and improved treatment outcomes.

OBJECTIVE

This integrative review aimed to elucidate how patient education on ICI efficacy and toxicity management affects patients with cancer and their family caregivers' self-efficacy and self-management when dealing with irAEs.

METHODS

An integrative review was conducted. EMBASE, MEDLINE, CINAHL, PsycINFO, and Scopus were searched for original research articles. Studies on educational interventions related to ICI and how it affects self-efficacy and self-management of irAEs were included. Data were analyzed using thematic analysis.

RESULTS

Of 4182 references screened; seven studies were included. Three themes emerged: (a) Feasibility of various strategies in patient education, (b) The effect of patient education on self-efficacy, and (c) Determinants to improve self-management of irAEs.

CONCLUSION

While traditional patient education methods (oral and/or written information) remain valuable, integrating digital technologies is promising to enhance understanding of ICI. Patient education, especially when combined with follow-up, can improve health-related quality of life and self-efficacy. However, health literacy plays a critical role in treatment and management of irAEs, emphasizing the need for personalized education approaches.

TRIAL REGISTRATION

The protocol is registered with PROSPERO (No. CRD42024511513).

摘要

背景

免疫检查点抑制剂(ICI)改善了癌症治疗,但这种治疗可能会导致免疫相关不良事件(irAE)。有效的患者及护理人员教育对于更好地管理irAE和改善治疗结果至关重要。

目的

本综合综述旨在阐明关于ICI疗效和毒性管理的患者教育如何影响癌症患者及其家庭护理人员在应对irAE时的自我效能感和自我管理能力。

方法

进行了一项综合综述。在EMBASE、MEDLINE、CINAHL、PsycINFO和Scopus数据库中检索原创研究文章。纳入了与ICI相关的教育干预措施及其如何影响irAE自我效能感和自我管理能力的研究。采用主题分析法对数据进行分析。

结果

在筛选的4182篇参考文献中,纳入了7项研究。出现了三个主题:(a)患者教育中各种策略的可行性,(b)患者教育对自我效能感的影响,以及(c)改善irAE自我管理的决定因素。

结论

虽然传统的患者教育方法(口头和/或书面信息)仍然很有价值,但整合数字技术有望增强对ICI的理解。患者教育,尤其是与随访相结合时,可以改善健康相关生活质量和自我效能感。然而,健康素养在irAE的治疗和管理中起着关键作用,这强调了个性化教育方法的必要性。

试验注册

该方案已在PROSPERO注册(编号CRD42024511513)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b511/11865008/fa65c739eae6/PON-34-e70100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b511/11865008/50088986dde4/PON-34-e70100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b511/11865008/fa65c739eae6/PON-34-e70100-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b511/11865008/50088986dde4/PON-34-e70100-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b511/11865008/fa65c739eae6/PON-34-e70100-g001.jpg

相似文献

1
Patient and Caregiver Education to Support Self-Efficacy and Self-Management During Immunotherapy-An Integrative Review.支持免疫治疗期间自我效能和自我管理的患者及护理人员教育——一项综合综述
Psychooncology. 2025 Mar;34(3):e70100. doi: 10.1002/pon.70100.
2
Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis.癌症患者发生免疫相关不良反应后再次使用免疫检查点抑制剂的安全性和疗效:系统评价和荟萃分析。
Front Immunol. 2021 Sep 27;12:730320. doi: 10.3389/fimmu.2021.730320. eCollection 2021.
3
Immune checkpoint inhibitor colitis, a rising issue in targeted cancer therapy era: A literature review.免疫检查点抑制剂相关性结肠炎,靶向肿瘤治疗时代的一个新问题:文献复习
Rom J Intern Med. 2024 Apr 9;62(3):219-230. doi: 10.2478/rjim-2024-0015. Print 2024 Sep 1.
4
Multidisciplinary Educational Program to Standardize Education and Management of Immune-related Adverse Events: Review and Outcomes of a Single-institution Initiative.多学科教育计划规范免疫相关不良事件的教育和管理:单机构计划的回顾和结果。
Am J Clin Oncol. 2024 Sep 1;47(9):419-424. doi: 10.1097/COC.0000000000001112. Epub 2024 May 17.
5
Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy.癌症免疫治疗中免疫检查点抑制剂的风湿性不良事件。
Expert Rev Clin Immunol. 2024 Aug;20(8):873-893. doi: 10.1080/1744666X.2024.2323966. Epub 2024 Mar 19.
6
Association between immune-related side effects and efficacy and benefit of immune checkpoint inhibitors - A systematic review and meta-analysis.免疫相关不良反应与免疫检查点抑制剂疗效和获益的关系:系统评价和荟萃分析。
Cancer Treat Rev. 2021 Jan;92:102134. doi: 10.1016/j.ctrv.2020.102134. Epub 2020 Dec 3.
7
Patients' experiences of cancer immunotherapy with immune checkpoint inhibitors: A systematic review and thematic synthesis.患者对免疫检查点抑制剂癌症免疫疗法的体验:系统评价和主题综合分析。
J Clin Nurs. 2024 Aug;33(8):2885-2904. doi: 10.1111/jocn.17154. Epub 2024 Apr 8.
8
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity.多国癌症支持治疗协会(MASCC)2020 年免疫相关不良反应管理临床实践建议:肺毒性。
Support Care Cancer. 2020 Dec;28(12):6145-6157. doi: 10.1007/s00520-020-05708-2. Epub 2020 Sep 3.
9
Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer.肺癌免疫检查点抑制剂相关的眼部免疫相关不良事件。
Front Immunol. 2021 Aug 24;12:701951. doi: 10.3389/fimmu.2021.701951. eCollection 2021.
10
Pilot Randomized Trial of an Educational Intervention About Immunotherapy for Patients With Advanced Cancer and Their Caregivers.针对晚期癌症患者及其护理人员的免疫治疗教育干预的试点随机试验。
J Natl Compr Canc Netw. 2025 Feb;23(2):12-20. doi: 10.6004/jnccn.2024.7079.

引用本文的文献

1
Experience and Needs of Immunotherapy for Lung Cancer Patients: A Meta-Synthesis of Qualitative Studies.肺癌患者免疫治疗的经验与需求:定性研究的元整合
Psychooncology. 2025 Jul;34(7):e70211. doi: 10.1002/pon.70211.

本文引用的文献

1
Electronic health intervention to manage symptoms of immunotherapy in patients with cancer (SOFIA): Results from a randomized controlled pilot trial.电子健康干预措施管理癌症患者免疫治疗相关症状(SOFIA):一项随机对照试点试验的结果。
Cancer. 2024 Jul 15;130(14):2503-2514. doi: 10.1002/cncr.35300. Epub 2024 Apr 2.
2
Mobile health interventions for cancer patient education: A scoping review.用于癌症患者教育的移动健康干预措施:一项范围综述。
Int J Med Inform. 2023 Nov;179:105214. doi: 10.1016/j.ijmedinf.2023.105214. Epub 2023 Sep 9.
3
Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer.
免疫检查点抑制剂与植物化学物质联合使用作为一种新型抗癌治疗策略。
J Cancer. 2023 Jul 24;14(12):2315-2328. doi: 10.7150/jca.85966. eCollection 2023.
4
Feasibility and preliminary effectiveness of virtual reality as a patient education tool for people with cancer undergoing immunotherapy: a protocol for a randomised controlled pilot study in a regional setting.虚拟现实作为癌症免疫治疗患者教育工具的可行性和初步效果:一项在区域环境中进行的随机对照初步研究方案。
BMJ Open. 2023 Jun 13;13(6):e071080. doi: 10.1136/bmjopen-2022-071080.
5
Efficacy of a Patient Education Session for Cancer Patients Receiving Immunotherapy.免疫治疗癌症患者患者教育课程的效果。
Semin Oncol Nurs. 2023 Aug;39(4):151445. doi: 10.1016/j.soncn.2023.151445. Epub 2023 May 11.
6
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer.检查点抑制剂作用机制概述:免疫相关不良事件的作用及其治疗对潜在癌症进展的影响
Front Med (Lausanne). 2022 May 30;9:875974. doi: 10.3389/fmed.2022.875974. eCollection 2022.
7
Educating the cancer patient about the immunotherapy toxicity: a descriptive observational study.对癌症患者进行免疫治疗毒性教育:一项描述性观察研究。
Prof Inferm. 2021 Oct-Dec;74(4):262. doi: 10.7429/pi.2021.744262b.
8
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre.《在癌症项目中实施免疫检查点抑制剂的指南:来自加拿大大型社区中心的经验》。
Curr Oncol. 2022 Feb 4;29(2):869-880. doi: 10.3390/curroncol29020074.
9
Virtual reality as a patient education tool in healthcare: A scoping review.虚拟现实作为医疗保健中的患者教育工具:一项范围综述。
Patient Educ Couns. 2022 Jul;105(7):1928-1942. doi: 10.1016/j.pec.2022.02.005. Epub 2022 Feb 10.
10
Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial.患者报告结局对检查点抑制剂治疗期间症状监测的影响:一项随机对照试验中黑色素瘤患者的健康相关生活质量
J Patient Rep Outcomes. 2022 Jan 21;6(1):8. doi: 10.1186/s41687-022-00414-5.